EcoDrugPlus

Phosphodiesterase 7b

Ensembl ID : ENSCMIG00000016487
Gene Symbol: PDE7B
4 Cross references
174 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSCMIG00000018842
Gene Symbol: PIK3R1
4 Cross references
259 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSCMIG00000006897
Gene Symbol: PIK3R2
4 Cross references
253 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSCMIG00000009637
Gene Symbol: PIK3R3
3 Cross references
277 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSCMIG00000017876
Gene Symbol: PIK3R5
4 Cross references
256 Possible Orthologues:

Phospholipase A2 Group Vii

Ensembl ID : ENSCMIG00000009455
Gene Symbol: PLA2G7
4 Cross references
206 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase, Phosphoribosylglycinamide Synthetase, Phosphoribosylaminoimidazole Synthetase

Ensembl ID : ENSCMIG00000016456
Gene Symbol: GART
3 Cross references
216 Possible Orthologues:

Plasminogen Activator, Urokinase

Ensembl ID : ENSCMIG00000009309
Gene Symbol: PLAU
3 Cross references
210 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSCMIG00000016313
Gene Symbol: PTAFR
4 Cross references
224 Possible Orthologues:

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSCMIG00000012550
Gene Symbol: PDGFRA
4 Cross references
201 Possible Orthologues:

Platelet-Derived Growth Factor Subunit A-Like

Ensembl ID : ENSCMIG00000018931
Gene Symbol: LOC103175503
3 Cross references
263 Possible Orthologues:

Polo Like Kinase 1

Ensembl ID : ENSCMIG00000012738
Gene Symbol: PLK1
4 Cross references
188 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).